Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

6.05

-0.24 (-3.82%)

At close: Jun 8, 2026, 4:00 PM EDT

6.05

0.00 (0.00%)

After-hours: Jun 8, 2026, 4:10 PM EDT

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	553	645	1,044	1,968	506	29
Market Cap Growth	-39.49%	-38.27%	-46.93%	289.25%	1669.60%	-79.48%
Enterprise Value	496.51	628.81	1,054	2,029	510.17	-17.88
Last Close Price	6.05	7.06	12.10	25.69	7.95	13.65
PE Ratio	-	353.00	242.00	-	265.00	56.88
PS Ratio	4.66	5.53	9.87	17.34	4.94	3.89
PB Ratio	5.67	6.08	16.49	-124.32	11.89	0.70
P/TBV Ratio	5.81	6.87	19.55	-106.85	14.15	22.16
P/FCF Ratio	177.51	-	-	113.25	88.81	-
P/OCF Ratio	126.30	638.29	-	76.00	47.35	-
EV/Sales Ratio	4.24	5.39	9.96	17.88	4.99	-2.44
EV/EBITDA Ratio	97.87	45.02	59.49	-	49.58	0.20
EV/EBIT Ratio	205.51	54.74	65.19	-	55.43	0.20
EV/FCF Ratio	161.57	-	-	116.76	89.63	0.21
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.00	0.01
Debt / EBITDA Ratio	0.33	0.07	0.09	-	0.06	-
Debt / FCF Ratio	0.27	-	-	0.02	0.11	-
Net Debt / Equity Ratio	-0.48	-0.49	-0.40	2.09	-0.58	-1.08
Net Debt / EBITDA Ratio	-19.78	-3.69	-1.42	0.50	-2.39	0.51
Net Debt / FCF Ratio	-15.94	286.03	4.21	-1.90	-4.32	0.53
Asset Turnover	0.71	0.80	0.87	1.13	1.46	0.10
Inventory Turnover	-	-	1.81	0.89	1.57	-
Quick Ratio	3.87	4.89	2.86	2.51	3.46	3.44
Current Ratio	4.64	5.60	3.32	2.85	4.06	3.63
Return on Equity (ROE)	-2.66%	8.21%	31.86%	-198.41%	7.61%	-150.11%
Return on Assets (ROA)	0.57%	5.39%	10.30%	-74.19%	6.01%	-116.80%
Return on Invested Capital (ROIC)	0.95%	8.40%	15.70%	-123.49%	14.91%	-1222.87%
Return on Capital Employed (ROCE)	-0.10%	9.05%	15.97%	-79.56%	16.14%	-148.28%
Earnings Yield	-	0.28%	0.41%	-	0.38%	1.76%
FCF Yield	0.56%	-	-	0.88%	1.13%	-
Buyback Yield / Dilution	11.33%	-0.87%	-55.39%	13.02%	-13.45%	-5117.44%
Total Shareholder Return	11.33%	-0.87%	-55.39%	13.02%	-13.45%	-5117.44%

SEC Filings: 10-K · 10-Q